RILEXINE® (cephalexin) Chewable Tablets provide convenient at-home dosing for the duration of the treatment plan and is available in 3 sizes of tablets and bisected scoring making it easier to get an exact dose.
Studies confirm RILEXINE® Tablets are the tasty solution that may improve compliance.
- Palatability and acceptance studies clearly demonstrate that dogs will readily take RILEXINE Tablets1, 2
- In one study, over 80% of dogs voluntarily accepted RILEXINE Tablets1
- In a second study, RILEXINE Tablets scored higher than 78% on overall palatability2
RILEXINE Tablets are more than palatable – they’re effective.
- RILEXINE Tablets are effective against Staphylococcus pseudintermedius – the organism responsible for approximately 90% of canine pyoderma cases3, 4
RILEXINE® (cephalexin) Chewable Tablets - Contraindicated in dogs with a known allergy to penicillins or cephalosporins. For oral use in dogs only. Not for use in humans. Individuals sensitive to penicillins or cephalosporins should avoid contact of the product with the skin and mucous membranes. Do not prescribe in the absence of a proven or strongly suspected bacterial infection. Safety in breeding, pregnant, or lactating bitches has not been evaluated. The most common adverse reactions in dogs include vomiting, diarrhea, anorexia and lethargy. For complete product information refer to the product insert. To obtain a package insert, contact Veterinary Technical Product Support at 1-800-338-3659.
Available by prescription only.
- Sponsor study #646.06-000-30013 Palatability of 646.06 (Cephalexin monohydrate) in client owned dogs, 2007.
- Sponsor study #646.06-000-30014 Palatability of 646.06 (Cephalexin monohydrate) in client owned dogs, 2007.
- Hannigan M. Pyoderma. In: Cote E, ed. Clinical Veterinary Advisor Dogs and Cats. St. Louis, MO: Mosby, Inc; 2007:930–932.
- Hnilica KA, Bacterial skin diseases. In: Small Animal Dermatology: A Color Atlas and Therapeutic Guide. 3rd ed. St. Louis, MO: Saunders; 2011:37-82.